Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J R Marks

Showing results (41-50 of 72) with videos related to

Pageof 8
Sort By:
American Journal of Obstetrics and Gynecology|September 1, 1996
Role of BRCA1 mutation screening in the management of familial ovarian cancerA Berchuck, F Cirisano, J M Lancaster, et al.
Cancer Research|October 15, 1996
Cell cycle control of BRCA2J P Vaughn, F D Cirisano, G Huper, et al.
Cancer Research|April 1, 1994
Mutation analysis of the THRA1 gene in breast cancer: deletion/fusion of the gene to a novel sequence on 17q in the BT474 cell lineP A Futreal, C Cochran, J R Marks, et al.
Nucleic Acids Research|November 15, 1996
Inhibition of the erbB-2 tyrosine kinase receptor in breast cancer cells by phosphoromonothioate and phosphorodithioate antisense oligonucleotidesJ P Vaughn, J Stekler, S Demirdji, et al.
Cancer Research|May 1, 1992
Detection of frequent allelic loss on proximal chromosome 17q in sporadic breast carcinoma using microsatellite length polymorphismsP A Futreal, P Söderkvist, J R Marks, et al.
American Journal of Obstetrics and Gynecology|November 1, 1996
p53 overexpression in advanced-stage endometrial adenocarcinomaM F Kohler, P Carney, R Dodge, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 29, 1995
Antisense DNA downregulation of the ERBB2 oncogene measured by a flow cytometric assayJ P Vaughn, J D Iglehart, S Demirdji, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 1, 1996
Relationship between p21 expression and mutation of the p53 tumor suppressor gene in normal and malignant ovarian epithelial cellsA A Elbendary, F D Cirisano, A C Evans, et al.
Cancer Research|August 2, 2001
A SAGE (serial analysis of gene expression) view of breast tumor progressionD A Porter, I E Krop, S Nasser, et al.
Surgery|August 1, 1991
Relation between p53 overexpression and established prognostic factors in breast cancerA M Davidoff, J E Herndon, N S Glover, et al.
Pageof 8

Showing results (41-50 of 72) with videos related to

Sort By:
Pageof 8
American Journal of Obstetrics and Gynecology|September 1, 1996
Role of BRCA1 mutation screening in the management of familial ovarian cancerA Berchuck, F Cirisano, J M Lancaster, et al.
Cancer Research|October 15, 1996
Cell cycle control of BRCA2J P Vaughn, F D Cirisano, G Huper, et al.
Cancer Research|April 1, 1994
Mutation analysis of the THRA1 gene in breast cancer: deletion/fusion of the gene to a novel sequence on 17q in the BT474 cell lineP A Futreal, C Cochran, J R Marks, et al.
Nucleic Acids Research|November 15, 1996
Inhibition of the erbB-2 tyrosine kinase receptor in breast cancer cells by phosphoromonothioate and phosphorodithioate antisense oligonucleotidesJ P Vaughn, J Stekler, S Demirdji, et al.
Cancer Research|May 1, 1992
Detection of frequent allelic loss on proximal chromosome 17q in sporadic breast carcinoma using microsatellite length polymorphismsP A Futreal, P Söderkvist, J R Marks, et al.
American Journal of Obstetrics and Gynecology|November 1, 1996
p53 overexpression in advanced-stage endometrial adenocarcinomaM F Kohler, P Carney, R Dodge, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 29, 1995
Antisense DNA downregulation of the ERBB2 oncogene measured by a flow cytometric assayJ P Vaughn, J D Iglehart, S Demirdji, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 1, 1996
Relationship between p21 expression and mutation of the p53 tumor suppressor gene in normal and malignant ovarian epithelial cellsA A Elbendary, F D Cirisano, A C Evans, et al.
Cancer Research|August 2, 2001
A SAGE (serial analysis of gene expression) view of breast tumor progressionD A Porter, I E Krop, S Nasser, et al.
Surgery|August 1, 1991
Relation between p53 overexpression and established prognostic factors in breast cancerA M Davidoff, J E Herndon, N S Glover, et al.
Pageof 8